Case 16-2007: A 61-year-old man with a mediastinal mass

New England Journal of Medicine

Volumn 356, Issue 21, 2007, Pages 2185-

  Wright, Cameron D ^a,b   Fidias, Panos ^a,b   Choi, Noah C H ^a,b   Shepard, Jo Anne O ^a,b   Hasserjian, Robert P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GABAPENTIN; LISINOPRIL; PREDNISONE; SIMVASTATIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADD ON THERAPY; ADULT; ANAMNESIS; ARTICLE; BRONCHOSCOPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATORY VOLUME; FROZEN SECTION; HUMAN; HYPERPARATHYROIDISM; LYMPHADENOPATHY; MALE; MEDIASTINOSCOPY; MEDIASTINUM MASS; PARATHYROIDECTOMY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; THYMOMA; BIOPSY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; MEDIASTINUM DISEASE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MEDIASTINAL DISEASES; MIDDLE AGED; NEOPLASM STAGING; THYMOMA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249663173     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc079010     Document Type: Article

References (40)

1. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-51.
2. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9.
3. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA 2000;283:1142-3.
4. Rosai J, Levine GD. Tumors of the thymus. In: Fuminger HI, ed. Atlas of tumor pathology. 2nd series. Fascicle 13. Washington, DC: Armed Forces Institute of Pathology, 1976:34-101.
5. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J West Soc Periodontol Periodontal Abstr 1961;42:424-44.
6. Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 1985;407:119-49.
7. Kuo T. Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 2000;36:403-14.
8. Shimosato Y, Mukai K. Tumors of the mediastinum. In: Rosai J, ed. Atlas of tumor pathology. 3rd series. Fascicle 21. Washington, DC: Armed Forces Institute of Pathology, 1997:93-115.
9. Marx A, Strobel P, Zettl A, et al. Thymomas. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Tumors of the lung, pleura, thymus and heart. Lyon, France: IARC Press, 2004:145-71.
10. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects oncologic behavior of thymom: a clinical study of 273 patients. Cancer 2002;94:624-32.
11. Quintanilla-Martinez L, Wilkins EW Jr, Ferry JA, Harris NL. Thymoma - morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 1993;24:958-69.
12. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independent prognostic factor. Cancer 1994;74:606-17.
13. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
14. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-85.
15. Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 2004;183:283-9.
16. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005;130:1413-21.
17. Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: is it necessary? Ann Thorac Surg 2005;79:1834-9.
18. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 2002;74:1033-7.
19. Tiseo M, Monetti F, Ferrarini M, Serrano J, Chiaramondia M, Ardizzoni A. Case 1: complete remission to corticosteroids in an octreotide-refractory thymoma. J Clin Oncol 2005;23:1578-9.
20. Hu E, Levine J. Chemotherapy of malignant thymoma: case report and review of the literature. Cancer 1986;57:1101-4.
21. Palmieri G, Montella L, Martignetti A, et al. Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 2002;94:1414-20.
22. Loehrer PJ, Wang W, Aisner S, et al. Long term follow up of patients with locally advanced or metastatic thymic malignancies: the Eastern Cooperative Oncology Group (ECOG) experience. J Clin Oncol 2004;22:Suppl 14:7050. abstract.
23. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma: a 13-year experience. Cancer 1991;68:30-3.
24. Loehrer PJ Sr, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91:2010-5.
25. Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996;14:814-20.
26. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004;44:369-79.
27. Bretti S, Berruti A, Loddo C, et al. Multimodal management of stages III-IVa malignant thymoma. Lung Cancer 2004;44:69-77.
28. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76:1866-72.
29. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT III. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-7.
30. Krueger JB, Sagerman RH, King GA. Stage III thymoma: results of postoperative radiation therapy. Radiology 1988;168:855-8.
31. Ciernik IF, Meier U, Lütolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994;12:1484-90.
32. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990;19:273-80.
33. Mornex F, Resbeut M, Richaud P, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicenter retrospective review of 90 cases. Int J Radiat Oncol Biol Phys 1995;32:651-9.
34. Cowen D, Richaud F, Mornex T, et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. Radiother Oncol 1995;34:9-16.
35. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-9.
36. Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 1992;54:311-5.
37. Myojin M, Choi NC, Wright CD, et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000;46:927-33.
38. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9415 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001;121:472-83.
39. Pottgen C, Levegrun S, Theegarten D, et al. Value of 18F-fluoro-2-deoxy- D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 2006;12:97-106.
40. Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998;129:100-4.